LSE - Delayed Quote GBp
Bioventix PLC (BVXP.L)
2,500.00
0.00
(0.00%)
At close: April 24 at 4:25:59 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | 1.51 | 0 |
| Low Estimate | 0 | 0 | 1.51 | 0 |
| High Estimate | 0 | 0 | 1.51 | 0 |
| Year Ago EPS | -- | -- | 1.55 | 1.51 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 13.5M | -- |
| Low Estimate | -- | -- | 13.5M | -- |
| High Estimate | -- | -- | 13.5M | -- |
| Year Ago Sales | -- | -- | 13.61M | -- |
| Sales Growth (year/est) | -- | -- | -0.78% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.51 | 0 |
| 7 Days Ago | 0 | 0 | 1.71 | 0 |
| 30 Days Ago | 0 | 0 | 1.71 | 0 |
| 60 Days Ago | 0 | 0 | 1.71 | 0 |
| 90 Days Ago | 0 | 0 | 1.71 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BVXP.L | -- | -- | -2.57% | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
GXE.BE Galapagos NV
23.04
+2.77%
4880.T CellSource Co., Ltd.
648.00
+0.62%
HVO.L hVIVO plc
16.35
-0.15%
FARN.L Faron Pharmaceuticals Oy
202.50
-3.57%
IBT.L International Biotechnology Trust plc
586.00
+1.03%
AVCT.L Avacta Group Plc
31.00
-6.06%
ONT.L Oxford Nanopore Technologies plc
122.10
+1.33%
GLPG.AS Galapagos NV
22.98
+2.32%
RIGL Rigel Pharmaceuticals, Inc.
19.06
+4.96%
GMAB.CO Genmab A/S
1,340.00
+0.75%